Market Highlights

• Portal Innovations, the new UChicago sciences incubator, has opened a 22,000-square-foot (sf) facility on the fifth floor of Hyde Park Labs to attract early-stage companies.
• Chan Zuckerberg Biohub and Portal Innovations expanded their leases at Fulton Labs at 400 North Aberdeen, while P33 Chicago relocated its headquarters within the Trammell Crow-owned development.
• Life sciences venture capital (VC) funding in the Chicago area declined after peaking in 2022 but has already surpassed the totals for both 2023 and 2024, reaching $640.1 million across 24 deals.

Read the full report